Abiopharma

News list

Rabinowitz Matthew 🟡 adjusted position in 0 shares (1 derivative) of Natera, Inc. (NTRA) at $9.59 Transaction Date: Mar 31, 2026 | Filing ID: 000005

Full text

News bot April 2, 2026, 1:05 a.m.
🔍 Rabinowitz Matthew (Executive)

Company: Natera, Inc. (NTRA)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 41,708
- Total shares sold: 41,708
- Total shares held: 5,000
Detailed Transactions and Holdings:
- Acquired 41,708 shares of Common Stock at $9.59 per share (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,352,480.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: By spouse | shares_owned_after: 5,000.00
- Sold 41,708 shares of Stock Option (right to buy) at $9.59 per share (Derivative)
  Date: 2026-03-31 | Code: M | Expires: 2026-04-07 | equity_swap_involved: 0 | shares_owned_after: 58,292.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The option shares are fully exercisable.